Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binayak Sinha

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Diabetes Research and Clinical Practice|March 10, 2022
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysisSamit Ghosal, Binayak Sinha
Diabetes & Metabolic Syndrome|December 3, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit Ghosal
Frontiers in Endocrinology|February 6, 2023
Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysisSamit Ghosal, Binayak Sinha
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 25, 2021
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled TrialsBinayak Sinha, Samit Ghosal
Obesity (Silver Spring, Md.)|July 21, 2025
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMABinayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 8, 2024
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL StudyBinayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 16, 2019
Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-AnalysisBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|December 4, 2014
Hypoglycaemia and CV risk: Perceptions and realitySamit Ghosal, Binayak Sinha
Addiction Science & Clinical Practice|December 5, 2025
The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysisBinayak Sinha, Samit Ghosal
Current Diabetes Reviews|October 26, 2019
Is it Worth CANVASing for CREDENCE? A Benefit-risk AnalysisBinayak Sinha, Samit Ghosal
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Diabetes Research and Clinical Practice|March 10, 2022
The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysisSamit Ghosal, Binayak Sinha
Diabetes & Metabolic Syndrome|December 3, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit Ghosal
Frontiers in Endocrinology|February 6, 2023
Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysisSamit Ghosal, Binayak Sinha
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 25, 2021
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled TrialsBinayak Sinha, Samit Ghosal
Obesity (Silver Spring, Md.)|July 21, 2025
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMABinayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 8, 2024
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL StudyBinayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 16, 2019
Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-AnalysisBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|December 4, 2014
Hypoglycaemia and CV risk: Perceptions and realitySamit Ghosal, Binayak Sinha
Addiction Science & Clinical Practice|December 5, 2025
The effects of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on alcohol-related outcomes: a systematic review and meta-analysisBinayak Sinha, Samit Ghosal
Current Diabetes Reviews|October 26, 2019
Is it Worth CANVASing for CREDENCE? A Benefit-risk AnalysisBinayak Sinha, Samit Ghosal
Pageof 4